Vijil Rahulan

• Residency in Internal Medicine and Fellowship in Pulmonary Medicine from Albert Einstein College of Medicine, New York, USA.
• Fellowship in Critical Care medicine from Wayne State University, Detroit, Michigan, USA.
• Further training in Interventional Pulmonology at Lahey Clinic, Massachusetts, USA and in Lung Transplantation at Barnes Jewish Medical Center, St Louis, Missouri, USA.
• Seven years of full time consultative practice experience in USA in the field of Pulmonolgy, Critical Care and Sleep Medicine.
• Current Position:Additional Director, KIMS Heart & Lung Transplant Institute
• Chief, Transplant Pulmonology, Krishna Institute of Medical Sciences, Minister Road, Secunderabad, Telangana, India ( from June 2020)
• Formerly H.O.D, Pulmonary/Critical Care & Senior Transplant Pulmonologist
Institute of Pulmonary, Critical Care Medicine & Lung Transplantation At Gleneagles Global Health city, Chennai (from 2009 till May 2020)
• Actively involved in the first lung transplant done in India in 2011
• Experience of more than 150lung transplantations since 2011

M.D,FCCP, FACP (USA), AB(Int. Medicine, Pulmonary & Critical Care Medicine)

Recognition:

• Elected Fellow of American College of Physicians, American College of Chest Physicians and is a member of American Society of Critical Care medicine and American association of Bronchology.
• Executive Committee Member of Indian Society of Heart and Lung Transplantation
• Member of Indian Chest Society, Chest Council of India, Indian Society of Critical Care Medicine

1. First Series of Combined Heart & Lung Transplantation from IndiaApril 2020, The Journal of Heart and Lung Transplantation39(4):S387
2. DOI: 10.1016/j.healun.2020.01.505
3. AIRWAY COMPLICATIONS POST LUNG TRANSPLANTATION: LARGEST SINGLE CENTER INDIAN EXPERIENCEJune 2020, CHEST 157(6):A450
4. DOI:10.1016/j.chest.2020.05.510
5. Tailored Immunosuppression Using CYP3A5 Metaboliser Status in Heart and Lung Transplant Cases - An Indian StudyApril 2020, The Journal of Heart and Lung Transplantation39(4):S504
6. DOI: 10.1016/j.healun.2020.01.107
7. Pulmonary alveolar microlithiasis: A rare disease treated with lung transplantation, first case from IndiaNovember 2019, Lung India 36(6):546
8. DOI: 10.4103/lungindia.lungindia_50_19
9. Correlation of Tacrolimus Levels and Metabolizer Status Based on CYP3A5 Polymorphism in Indian Lung Transplant RecipientsApril 2019, The Journal of Heart and Lung Transplantation38(4):S410
10. DOI: 10.1016/j.healun.2019.01.1045
11. A real life experience on the efficacy and safety of mycophenolatemofetil in connective tissue disorder associated interstitial lung disease – a retrospective studyJune 2018, Annals of the Rheumatic Diseases 77(Suppl 2):1533-1533
12. DOI: 10.1136/annrheumdis-2018-eular.3395
13. Establishing a Lung Transplant Program in a Resource Constrained SettingApril 2018, The Journal of Heart and Lung Transplantation37(4):S255
14. DOI:10.1016/j.healun.2018.01.635
15. Complications and management of attempted suicide by intrapleural injection of prallethrinMarch 2016, Indian Journal of Critical Care Medicine20(3):182
16. DOI:10.4103/0972-5229.178184
17. Single lung transplantation in India: an initial experienceSeptember 2013, The Indian journal of chest diseases & allied sciences 55(2):101-3
18. Endobronchial cryptococcosis: A rare cause of lung collapseJanuary 2010, Journal of Bronchology and Interventional Pulmonology 17(1):76-9
19. DOI:10.1097/LBR.0b013e3181cd95da